- EFA’s research on asthma in adolescence will be presented in Gastein
- Our latest survey on adherence to treatment of young patients with asthma will be presented at the European Health Forum Gastein (EHFG), the most influential EU health policy conference that will take ...
- Is pollen a pollutant? Our views at the European Aerobiology Symposium
- EFA was invited to open the European Symposium on Aerobiology celebrated in Lyon from the 18th-22nd July. The event was organised by the European Aerobiology Society and aimed to share latest research ...
- More research into earlier diagnosis – Our response to H2020 consultation
- During the summer, EFA had the chance to provide feedback on the development of the work programme 2018-2020 of Horizon 2020 (the European Union’s Research and Innovation Framework Programme) in respo ...
- Simplified clinical trials results to inform patients – Our response to the EC consultation
- In August we sent our comments to the European Commission open consultation on the summary of results of clinical trials for laypersons. This consultation follows the new clinical trials regulation ...
- Call to Croatia and Serbia to reinforce tobacco control
- EFA co-signed with others 29 NGOs an open letter to the President and Government of the Republic of Croatia and of Serbia expressing deep concerns regarding the close relations between tobacco industr ...
- New consultation on the security of tobacco products – Open!
- EFA, in partnership with ENSP, is planning to reply to the open consultation with the purpose to collect inputs for implementing an EU system traceability and security features, as required under Arti ...
- Added-value of patient organisations – EPF survey
- EFA Director Susanna Palkonen is actively participating at EPF Working Group on sustainability of patient organisations, which drafted a survey to demonstrate the contribution of patient organisations ...
- Health and environment associations mobilized against TTIP once again
- In July, more than 60 non-profit associations sent a letter to the President of the European Parliament Martin Schulz arguing that the European Commission is failing to comply with Parliament’s 2015 R ...
- European Association of Systems Medicine Conference
- The European Association of Systems Medicine (EASyM) is organisation its first conference on October 26th-28th in Berlin, that will gather scientists from all over Europe, including physicians, biolog ...
- Vote for myAirCoach to win the EC Innovation Radar Prize
- The European Commission has listed the myAirCoach device as one of the high potential innovations in EU-funded research and innovation projects for the Innovation Radar Prize 2016. myAirCoach partne ...
- New treatment to reduce asthma severity – Promising AirPROM study
- The University of Leicester has led a ground-breaking study, funded by Novartis Pharmaceuticals, National Institute for Health Research (NIHR) and EU-funded project AirPROM, on a new drug that may in ...
- AirPROM legacy – Check out the booklet
- The AirPROM project ended in May 2016, with a public event organised by EFA at the European Parliament, hosted by MEP David Borrelli. However the work does not finish when a project ends, especially w ...
- U-BIOPRED's role on patient involvement
- The Innovative Medicines Initiative (IMI) has published an interview with Professor Peter Sterk, coordinator of U-BIOPRED, one of the first projects launched by the IMI in 2009. According to Sterk, ...
- Chronic diseases in Europe: the Commission is urged to act
- EFA, the European Chronic Diseases Alliance (ECDA) and other public health organisations have sent an open letter to the European Commission urging them to act on chronic diseases. Chronic diseases ...
- The European Commission advances on “may contain” allergen labelling
- EFA brought to a European Commission workshop on precautionary labelling the patients perspective to abolish “may contain” mentions. With 17 million Europeans affected by food allergies, allergen info ...
- European Medicines Agency celebrates 10 years of collaboration with patients
- Our continuous input into the information, evaluation and safety and development policies of medicines in Europe is an achievement that we celebrate, especially after the renewal of EFA membership to ...
- EFA President moderates debate on care and research at EAACI Congress
- On the 13th of June, EFA President Mikaela Odemyr co-moderated a debate at a high-level policy meeting on the challenges and opportunities the European Union has to address allergy and asthma. This me ...
- EFA brings the patients’ perspective to the Medicines for Europe event
- On the 9th of June, EFA Senior EU Policy Adviser and Deputy Director Roberta Savli took part in a panel discussion on so-called value-added medicines organised in the framework of the Joint 22nd Medic ...
- European Patient Charter presented
- In the framework of the Patient Empowerment campaign, the European Patients’ Forum (EPF) has launched the European Patient Charter and a Roadmap for patient empowerment. EFA, as full Member and Board ...
- EU conclusions to make more balanced pharmaceutical systems
- On the 17th of June, the Council of the European Union issued conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States. The Council recognises the importa ...